The post Analysts Warn: A Wave of Altcoin Spot ETF Approvals Could Begin Tomorrow – Here’s What to Watch For appeared on BitcoinEthereumNews.com. A large number of cryptocurrency exchange-traded funds (ETFs) are expected to launch in the US this fall. While experts say this could be a significant turning point in digital asset access for both institutional and individual investors, there are also warnings that many products will fail. “The flood of crypto ETFs will begin this fall, and investors will be inundated with these products,” said Nate Geraci, President of NovaDius Wealth Management. Geraci expects more than 90 ETF applications currently submitted to the U.S. Securities and Exchange Commission (SEC) to be approved if they meet the necessary requirements. However, he emphasized that the final decision rests with the investor: “The great thing about the ETF market is that it’s a meritocracy; investors vote with their money. The market naturally separates winners from losers.” Geraci believes the demand for spot-based crypto ETFs is still under-appreciated. He also predicts strong demand for spot ETFs under the 1933 Act for assets like Solana and XRP, citing interest in Bitcoin and Ethereum ETFs as examples. The BlackRock-managed iShares Bitcoin Trust (IBIT) has become the most successful ETF launch in history and currently holds approximately $85 billion in BTC. While Ethereum-based ETFs initially saw less interest, inflows have accelerated in recent months amid rising demand for Ethereum. According to Bloomberg Intelligence analyst James Seyffart, Ether ETFs have received approximately $10 billion in inflows since the beginning of July, accounting for the majority of the $14 billion in total inflows since their launch last year. Geraci also noted increased interest in index-based crypto ETFs, saying they offer investors a simpler way to access the broader digital asset ecosystem. However, he acknowledged that demand for altcoin ETFs is more uncertain due to the underlying dynamics of the projects. Seyffart points out that despite the increase in the number… The post Analysts Warn: A Wave of Altcoin Spot ETF Approvals Could Begin Tomorrow – Here’s What to Watch For appeared on BitcoinEthereumNews.com. A large number of cryptocurrency exchange-traded funds (ETFs) are expected to launch in the US this fall. While experts say this could be a significant turning point in digital asset access for both institutional and individual investors, there are also warnings that many products will fail. “The flood of crypto ETFs will begin this fall, and investors will be inundated with these products,” said Nate Geraci, President of NovaDius Wealth Management. Geraci expects more than 90 ETF applications currently submitted to the U.S. Securities and Exchange Commission (SEC) to be approved if they meet the necessary requirements. However, he emphasized that the final decision rests with the investor: “The great thing about the ETF market is that it’s a meritocracy; investors vote with their money. The market naturally separates winners from losers.” Geraci believes the demand for spot-based crypto ETFs is still under-appreciated. He also predicts strong demand for spot ETFs under the 1933 Act for assets like Solana and XRP, citing interest in Bitcoin and Ethereum ETFs as examples. The BlackRock-managed iShares Bitcoin Trust (IBIT) has become the most successful ETF launch in history and currently holds approximately $85 billion in BTC. While Ethereum-based ETFs initially saw less interest, inflows have accelerated in recent months amid rising demand for Ethereum. According to Bloomberg Intelligence analyst James Seyffart, Ether ETFs have received approximately $10 billion in inflows since the beginning of July, accounting for the majority of the $14 billion in total inflows since their launch last year. Geraci also noted increased interest in index-based crypto ETFs, saying they offer investors a simpler way to access the broader digital asset ecosystem. However, he acknowledged that demand for altcoin ETFs is more uncertain due to the underlying dynamics of the projects. Seyffart points out that despite the increase in the number…

Analysts Warn: A Wave of Altcoin Spot ETF Approvals Could Begin Tomorrow – Here’s What to Watch For

A large number of cryptocurrency exchange-traded funds (ETFs) are expected to launch in the US this fall.

While experts say this could be a significant turning point in digital asset access for both institutional and individual investors, there are also warnings that many products will fail.

“The flood of crypto ETFs will begin this fall, and investors will be inundated with these products,” said Nate Geraci, President of NovaDius Wealth Management. Geraci expects more than 90 ETF applications currently submitted to the U.S. Securities and Exchange Commission (SEC) to be approved if they meet the necessary requirements. However, he emphasized that the final decision rests with the investor:

“The great thing about the ETF market is that it’s a meritocracy; investors vote with their money. The market naturally separates winners from losers.”

Geraci believes the demand for spot-based crypto ETFs is still under-appreciated. He also predicts strong demand for spot ETFs under the 1933 Act for assets like Solana and XRP, citing interest in Bitcoin and Ethereum ETFs as examples.

The BlackRock-managed iShares Bitcoin Trust (IBIT) has become the most successful ETF launch in history and currently holds approximately $85 billion in BTC. While Ethereum-based ETFs initially saw less interest, inflows have accelerated in recent months amid rising demand for Ethereum. According to Bloomberg Intelligence analyst James Seyffart, Ether ETFs have received approximately $10 billion in inflows since the beginning of July, accounting for the majority of the $14 billion in total inflows since their launch last year.

Geraci also noted increased interest in index-based crypto ETFs, saying they offer investors a simpler way to access the broader digital asset ecosystem. However, he acknowledged that demand for altcoin ETFs is more uncertain due to the underlying dynamics of the projects.

Seyffart points out that despite the increase in the number of ETFs, many products will not be able to hold up in the long run:

“If all of these applications are implemented, closures will be inevitable in the next few years,” he says. Seyffart emphasizes that expectations for altcoin-based ETFs shouldn’t be too high, adding, “Those expecting the success of Bitcoin ETFs will be disappointed. However, those who think they will all fail will be mistaken.”

*This is not investment advice.

Follow our Telegram and Twitter account now for exclusive news, analytics and on-chain data!

Source: https://en.bitcoinsistemi.com/analysts-warn-a-wave-of-altcoin-spot-etf-approvals-could-begin-tomorrow-heres-what-to-watch-for/

Market Opportunity
Bitcoin Logo
Bitcoin Price(BTC)
$95.499,9
$95.499,9$95.499,9
-1,31%
USD
Bitcoin (BTC) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale

5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale

BullZilla, World Liberty Financial, MoonBull, La Culex, and Polkadot (DOT) are taking the spotlight among emerging and established crypto projects […] The post 5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale appeared first on Coindoo.
Share
Coindoo2025/10/18 08:15
Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26